Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node

Cancer

Volumn 89, Issue 3, 2000, Pages 574-581

  Turner, Roderick R ^a,b   Chu, Kyo U ^a   Qi, Karen ^a   Botnick, Leslie E ^a   Hansen, Nora M ^a   Glass, Edwin C ^a   Giuliano, Armando E ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b SAINT JOHN'S HEALTH CENTER   (United States)

Author keywords

Breast carcinoma; Breast surgery; Metastases; Sentinel lymph node

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER INVASION; CANCER SIZE; CANCER STAGING; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; STATISTICS, NONPARAMETRIC;

EID: 0034255162     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000801)89:3<574::AID-CNCR12>3.0.CO;2-Y     Document Type: Article

References (34)

1. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
2. Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). X. Discriminants for tenth year treatment failure
3. Prognostic importance of occult axillary lymph node micrometastases from breast cancers
4. Axillary node micrometastases and breast cancer
5. Pathologic correlates of prognosis in lymph node-positive breast carcinomas
6. Lymph node micrometastases from breast carcinoma. Reviewing the dilemma
7. Occult axillary node metastases in breast cancer: Their detection and prognostic significance
8. Prognostic significance of occult lymph node metastases in node-negative breast cancer
9. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer
10. Prognosis in breast cancer patients with tumour cells in the efferent vessels of their axillary nodes
11. Prognostic features in patients with stage T1 breast carcinoma and a 0.5-cm or less lymph node metastasis
12. Breast cancer: Two micrometastatic variants in the axilla that differ in prognosis
13. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
14. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis
15. Development of sentinel node targeting technique in breast cancer patients
16. Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer?
17. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
18. Lymphoscintigraphy and lymphatic mapping for the identification of sentinel lymph nodes
19. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging
20. Clinical behavior of untreated axillary nodes after local treatment for primary breast cancer
21. Axillary dissection in breast cancer: When, why, how much, and for how long? Another operation soon to be extinct?
22. A survival benefit from axillary dissection: Was Halsted correct?
23. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
24. Improved axillary staging of breast cancer with sentinel lymphadenectomy
25. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer
26. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series
27. Lessons learned from 500 cases of lymphatic mapping for breast cancer
28. The sentinel node in breast cancer. A multicenter validation study
29. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
30. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma
31. Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis
32. Complications of axillary lymph node dissection for carcinoma of the breast
33. Therapeutic effect of sentinel lymphadenectomy in T1 breast cancer